BioCentury
ARTICLE | Top Story

MedImmune acquires CV company AlphaCore

April 3, 2013 11:32 PM UTC

The MedImmune LLC biologics unit of AstraZeneca plc (LSE:AZN; NYSE:AZN) acquired cardiovascular company AlphaCore Pharma (Ann Arbor, Mich.). Details of the deal were not disclosed. AlphaCore is develo...